Similar content being viewed by others Introduction Obesity affects approximately 39% of the worlds adult population which represents a threefold increase since 1975 [1]
Manu Chakravarthy, who oversees cardiovascular, renal, and metabolism product development at Roche, said the company must consider the full range of people living with obesity because the condition is heterogeneous, complex, and will require segmentation
Cardiovascul Diabetol
Tamburini S, Shen N, Wu HC, Clemente JC
Semaglutide and tirzepatide have revolutionized the treatment of obesity and type 2 diabetes, offering hope to patients who have struggled to achieve lasting results through diet and exercise alone
Blood sugar regulation : Improved insulin response helps prevent fat storage and energy crashes